1. Home
  2. TEVA vs DHI Comparison

TEVA vs DHI Comparison

Compare TEVA & DHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$35.37

Market Cap

39.5B

Sector

Health Care

ML Signal

HOLD

Logo D.R. Horton Inc.

DHI

D.R. Horton Inc.

HOLD

Current Price

$156.96

Market Cap

39.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TEVA
DHI
Founded
1901
1978
Country
Israel
United States
Employees
32842
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
39.5B
39.0B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
TEVA
DHI
Price
$35.37
$156.96
Analyst Decision
Strong Buy
Hold
Analyst Count
8
14
Target Price
$38.63
$166.08
AVG Volume (30 Days)
5.3M
2.2M
Earning Date
04-29-2026
04-21-2026
Dividend Yield
N/A
1.19%
EPS Growth
N/A
N/A
EPS
N/A
4.27
Revenue
N/A
$34,250,400,000.00
Revenue This Year
N/A
$0.05
Revenue Next Year
$2.97
$5.85
P/E Ratio
$28.19
$37.14
Revenue Growth
N/A
N/A
52 Week Low
$14.99
$129.11
52 Week High
$37.35
$183.62

Technical Indicators

Market Signals
Indicator
TEVA
DHI
Relative Strength Index (RSI) 59.63 52.04
Support Level $30.59 $145.76
Resistance Level $35.33 $162.93
Average True Range (ATR) 1.13 4.99
MACD 0.20 -0.39
Stochastic Oscillator 97.00 25.57

Price Performance

Historical Comparison
TEVA
DHI

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About DHI D.R. Horton Inc.

D.R. Horton is the largest homebuilder in the United States with operations in 126 markets across 36 states. D.R. Horton mainly builds single-family homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. The firm has majority ownership of Forestar Group, a publicly traded residential lot development company. D.R. Horton's headquarters are in Arlington, Texas.

Share on Social Networks: